Literature DB >> 1851786

Rapid determination of the elevated Na(+)-H+ exchange in platelets of patients with essential hypertension using an optical swelling assay.

D Rosskopf1, E Morgenstern, W Scholz, U Osswald, W Siffert.   

Abstract

Accumulating evidence suggests an increased activity of the Na(+)-H+ exchanger in essential hypertension. The present investigation aimed at developing a test for routine measurements. Platelet-rich plasma was added directly to a cuvette placed into an aggregometer containing 140 mmol/l sodium propionate medium (pH 6.7, 37 degrees C). The accumulation of intracellular sodium due to activation of Na(+)-H+ exchange results in an osmotic cell swelling, which is detectable as a decrease in optical density (OD). This reaction reflects activation of the Na(+)-H+ exchanger since we observed (1) a dose-dependent inhibition by amiloride (inhibition constant, Ki = 10 mumol/l) and ethylisopropylamiloride (Ki = 0.07 mumol/l) and (2) a dependence on extracellular sodium of the OD changes. Electron microscopy of sodium propionate-treated platelets revealed a general swelling and a distinct decrease in electron density of the cytosol without other significant alterations. Quantification of Na(+)-H+ exchange activities was accomplished by calculating rate constants of the recorded changes in OD. Application of this assay to 20 essential hypertensives and 32 normotensives demonstrated an increased activity of the Na(+)-H+ exchanger in essential hypertensives (rate constants 29.8 x 10(-3) per s versus 21.7 x 10(-3) per s).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851786

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  In vitro and in vivo pharmacology of a structurally novel Na+-H+ exchange inhibitor, T-162559.

Authors:  Keiji Kusumoto; Hideki Igata; Akemi Abe; Shota Ikeda; Ayako Tsuboi; Eikoh Imamiya; Shoji Fukumoto; Mitsuru Shiraishi; Toshifumi Watanabe
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

Review 2.  Sodium-hydrogen exchange and platelet function.

Authors:  D Rosskopf
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

3.  Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemia.

Authors:  W Scholz; U Albus; H J Lang; W Linz; P A Martorana; H C Englert; B A Schölkens
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

4.  Platelet Na+/H+ antiport activity in patients with insulin-dependent diabetes mellitus with and without diabetic nephropathy.

Authors:  R Düsing; M Sorger; L Mattes; B O Göbel; G Hoffmann; D Rosskopf; H Vetter; W Siffert
Journal:  Clin Investig       Date:  1993-02

5.  Cyclic nucleotides attenuate thrombin-evoked alterations in parameters of platelet Na/H antiport. The role of cytosolic Ca.

Authors:  M Kimura; N Lasker; A Aviv
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

6.  Cardioprotective efficacy of zoniporide, a potent and selective inhibitor of Na+/H+ exchanger isoform 1, in an experimental model of cardiopulmonary bypass.

Authors:  Hugh Clements-Jewery; Fiona J Sutherland; Mary C Allen; W Ross Tracey; Metin Avkiran
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.